Rebalix
Invesco · sheet of 5 September 2026
Invesco · sheet of 5 September 2026ETF sheet · official issuer and register data
Invesco Nasdaq-100 Income Advantage UCITS ETF Dist
QQIA · IE0007YZZZN7 · class Dist · USD · domicile Ireland
Equity · United StatesactiveSFDR art. 6
Comparison benchmark: NASDAQ - 100 Notional NTR Index
- TER
- 0.29%+ trans. 0.02%
- Fund size
- 8 m EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Activeactive management
- Income
- Distributingmonthly
Launch 27 Jan 2026 · costs from the KID as of 14 Aug 2026 · 103 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 14 Aug 2026
Investment objective: The objective of the Fund is to aim to provide total return through the provision of income and long-term capital growth. Dividend Policy: This Share Class declares and distributes a dividend on a monthly basis. Investment approach: The Fund is an actively managed ETF. To achieve the investment objective the Fund will generally: 1) invest in an ‘Equity Component’, which is designed to replicate the performance of the NASDAQ-100 Index®(the "Benchmark"). The Fund will invest in US equity securities in proportion to their weightings in…
Performance since series start (in euro) — base 100
27 Jan 2026 → 1 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | series too young |
| 3 years | series too young |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +9.7% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | — | — | — |
| Max drawdown | — | — | — |
| Sharpe | — | — | — |
| Sortino | — | — | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · QQIA · IE0007YZZZN71
RebalixQQIA · IE0007YZZZN7 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: active management: deviation from the index is management, not replication
Distributions · per share, in USD
Frequency: monthly · last 12 months: 0.8582 USD (4.08% of NAV) · 6 months of history: not a full year · last ex-date 10 Sept 2026
| Year | Payments | Total (USD) |
|---|---|---|
| 2026 | 6 | 1.0471 |
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 103 securities · top-10 weight = 57.3%
| Top holdings | Weight |
|---|---|
| 24.2% | |
| 6.4% | |
| 5.9% | |
| 4.6% | |
| 3.6% | |
| 3.4% | |
| 2.5% | |
| 2.4% | |
| 2.2% | |
| 2.2% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
QQIA · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 7 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE0007YZZZN7
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE0007YZZZN7
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · QQIA · IE0007YZZZN72